ADAM17 is expressed in atherosclerosis-prone sites, however it is not clear whether this expression is due to an up-regulation of enzyme expression or due to its expression by newly infiltrated vascular smooth muscle cells (VSMCs) and leukocytes (Canault et al., 2006). Here, ADAM17 is linked to atherosclerosis.